Enhanced Access to Affordable Medicines Act of 2022
Summary
Enhanced Access to Affordable Medicines Act of 2022 This bill specifies that the Food and Drug Administration may approve generic drugs with different labels than the brand-name versions if, among other requirements, a revised label for the brand-name drug is approved within 90 days of when the generic is otherwise eligible for approval.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2022
Committee Review
Floor Vote
President
Introduced Jun 6, 2022
Last action Jun 6, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jun 6, 2022
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Jun 6, 2022
Introduced
Introduced in Senate
upper
1 primary · 3 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Mitt Romney
RRepublican
Co
Jacky Rosen
DDemocratic
Co
John W. Hickenlooper
DDemocratic
Co
Margaret Wood Hassan
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4351
Scope: US
Hi! I can help you understand S 4351. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline